Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07807969
PHASE3

An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Sponsor: Annexon, Inc.

View on ClinicalTrials.gov

Summary

The primary purpose of the study is to assess the long term safety of intravitreal (IVT) injections of vonaprument.

Official title: A Multicenter, Open-Label Extension Study of the Long-Term Safety of Vonaprument (ANX007) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy

Key Details

Gender

All

Age Range

50 Years - Any

Study Type

INTERVENTIONAL

Enrollment

605

Start Date

2026-09-30

Completion Date

2029-07-31

Last Updated

2026-09-08

Healthy Volunteers

No

Interventions

DRUG

Vonaprument

Form: solution for injection; Route of Administration: IVT injection

Locations (7)

Retina Group of Florida

Sarasota, Florida, United States

Retina Vitreous Associates of Florida

St. Petersburg, Florida, United States

Cumberland Valley Retina Consultants

Hagerstown, Maryland, United States

Mid Atlantic Retina Specialists

Hagerstown, Maryland, United States

Retina Research Institute at New England Retina Consultants

Springfield, Massachusetts, United States

Asheville Eye Associates - Retina Division

Asheville, North Carolina, United States

Verum Research, LLC

Eugene, Oregon, United States